Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspire-Lakewood Holdings, Inc.ASBP · Entity 7885 | Director | June 04, 2025 | June 10, 2025 |
| Crown Reserve Acquisition Corp. ICRAC · Entity 6210 | Director | September 26, 2025 | October 23, 2025 |
| DataMeds AI, Inc.WGRX · Entity 8434 | Director | October 02, 2025 | October 21, 2025 |
| Flash Sports & Media Holdings, Inc.UGRO · Entity 8355 | Director | February 18, 2026 | April 10, 2026 |
| Integrated Wellness Acquisition CorpWEL · Entity 85241 | Director | February 12, 2024 | February 21, 2024 |
| Kernel Group Holdings, Inc.KRNL · Entity 111780 | Director | December 28, 2022 | March 28, 2023 |
| Ocean Biomedical, Inc.AEHA · Entity 8695 | Director | September 14, 2021 | September 20, 2021 |
| OceanTech Acquisitions I Corp.OTEC · Entity 112900 | Director | March 13, 2023 | April 21, 2023 |
| Scienture Holdings, Inc.MEDS · Entity 7802 | Director | September 01, 2022 | September 16, 2022 |
| Tevogen Inc.LGST · Entity 7276 | Director | June 07, 2023 | June 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspire-Lakewood Holdings, Inc.
Report date June 04, 2025 · Filed June 10, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 20,000 |
Last balance in matching sequence
After 2025-06-05 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-06-04 · Purchase · Acquired 9,500 · Balance 9,500 Row 2 · 2025-06-05 · Purchase · Acquired 10,500 · Balance 20,000 |
Crown Reserve Acquisition Corp. I
Report date September 26, 2025 · Filed October 23, 2025
This filing explicitly reported no securities owned.
DataMeds AI, Inc.
Report date October 02, 2025 · Filed October 21, 2025
This filing explicitly reported no securities owned.
Flash Sports & Media Holdings, Inc.
Report date February 18, 2026 · Filed April 10, 2026
This filing explicitly reported no securities owned.
Integrated Wellness Acquisition Corp
Report date February 12, 2024 · Filed February 21, 2024
This filing explicitly reported no securities owned.
Kernel Group Holdings, Inc.
Report date December 28, 2022 · Filed March 28, 2023
This filing explicitly reported no securities owned.
Ocean Biomedical, Inc.
Report date September 14, 2021 · Filed September 20, 2021
This filing explicitly reported no securities owned.
OceanTech Acquisitions I Corp.
Report date March 13, 2023 · Filed April 21, 2023
This filing explicitly reported no securities owned.
Scienture Holdings, Inc.
Report date September 01, 2022 · Filed September 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 75,664 |
Reported balance
After 2022-09-01 transaction · row 1
1 source rowRow 1 · 2022-09-01 · Grant · Acquired 54,525 · Balance 75,664 F1: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on the grant date, September 1, 2022, and 1/4th of such shares on each of October 1, 2022, January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on the grant date, September 1, 2022, and 1/4th of such shares on each of October 1, 2022, January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors.
Tevogen Inc.
Report date June 07, 2023 · Filed June 14, 2023
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2025 Filed Jun 6, 2025 21:00 UTC | Aspire-Lakewood Holdings, Inc. ASBP · Entity 7885 | PurchaseCommon Stock, par value $0.0001 | 10,500 | $0.39 | $4,095.00 |
DisclosureSEC source: 0001641172-25-014102 · ownership.xml · nonDerivative · entry 2 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| June 05, 2025 Filed Jun 10, 2025 21:25 UTC Amendment | Aspire-Lakewood Holdings, Inc. ASBP · Entity 7885 | PurchaseCommon Stock, par value $0.0001 | 10,500 | $0.39 | $4,095.00 |
DisclosureSEC source: 0001641172-25-014569 · ownership.xml · nonDerivative · entry 2 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 21:00 UTC | Aspire-Lakewood Holdings, Inc. ASBP · Entity 7885 | PurchaseCommon Stock, par value $0.0001 | 9,500 | $0.39 | $3,705.00 |
DisclosureSEC source: 0001641172-25-014102 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Read SEC document |
| June 04, 2025 Filed Jun 10, 2025 21:25 UTC Amendment | Aspire-Lakewood Holdings, Inc. ASBP · Entity 7885 | PurchaseCommon Stock, par value $0.0001 | 9,500 | $0.39 | $3,705.00 |
DisclosureSEC source: 0001641172-25-014569 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Read SEC document |
| September 01, 2022 Filed Sep 16, 2022 21:15 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 54,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-026109 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,664 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on the grant date, September 1, 2022, and 1/4th of such shares on each of October 1, 2022, January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | PurchaseCommon Stock | 1,500 | $1.08 | $1,620.00 |
DisclosureSEC source: 0001493152-22-024282 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,139 Read SEC document |
| May 12, 2022 Filed May 18, 2022 20:06 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | PurchaseCommon Stock | 2,000 | $1.26 | $2,520.00 |
DisclosureSEC source: 0001493152-22-014319 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,639 Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:31 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-010633 · ownership.xml · nonDerivative · entry 2 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,639 F1 · shares: This transaction involved a bona fide gift of securities by the Reporting Person to family and/or a friend. Read SEC document |
| May 04, 2021 Filed May 6, 2021 20:31 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-010633 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,939 F1 · shares: This transaction involved a bona fide gift of securities by the Reporting Person to family and/or a friend. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 20:35 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 10,721 | $5.13 | $54,998.73 |
DisclosureSEC source: 0001493152-21-009256 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,189 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2021 and January 1 and April 1, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · balance_after: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 02:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon stock | 500 | $5.30 | $2,650.00 |
DisclosureSEC source: 0001493152-20-023707 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,487 F1 · shares: The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the December 2020 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3. Read SEC document |
| December 14, 2020 Filed Apr 15, 2021 20:32 UTC Amendment | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon stock | 500 | $5.30 | $2,650.00 |
DisclosureSEC source: 0001493152-21-008892 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 F1 · shares: The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the December 2020 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3. F2 · balance_after: This Amended Form 4 is being filed to update the Reporting Person's beneficial ownership to include 981 shares of common stock which were inadvertently left out of the original filing. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 00:02 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 8,987 | $6.12 | $55,000.44 |
DisclosureSEC source: 0001493152-20-006501 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2020 and January 1 and April 1, 2021, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. Read SEC document |
| April 14, 2020 Filed Apr 15, 2021 20:31 UTC Amendment | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 8,987 | $6.12 | $55,000.44 |
DisclosureSEC source: 0001493152-21-008891 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,968 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2020 and January 1 and April 1, 2021, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. F3 · balance_after: This Amended Form 4 is being filed to update the Reporting Person's beneficial ownership to include 981 shares of common stock which were inadvertently left out of the original filing. Read SEC document |
| January 06, 2020 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 22 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981 Read SEC document |
| January 06, 2020 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 21 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Read SEC document |
| January 06, 2020 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 20 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381 Read SEC document |
| October 08, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 1,000 | $1.00 | $1,000.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 19 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,581 Read SEC document |
| October 04, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 18 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581 Read SEC document |
| August 09, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 17 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081 Read SEC document |
| August 09, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 16 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781 Read SEC document |
| August 09, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 15 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,281 Read SEC document |
| August 05, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 1,000 | $0.55 | $550.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 14 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 Read SEC document |
| July 09, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 13 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,281 Read SEC document |
| July 09, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 12 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 Read SEC document |
| July 02, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 200 | $0.62 | $124.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 11 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,281 Read SEC document |
| June 11, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 1,000 | $0.54 | $540.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 10 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 Read SEC document |
| May 13, 2019 Filed May 16, 2019 15:29 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001078782-19-000454 · primary_doc.xml · derivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,048 Underlying: Common Stock · 50,000 shares Expires 2029-05-13 F1 · derivative.exercise_date: Option vests and becomes exercisable quarterly over four years. Read SEC document |
| April 11, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 9 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,081 Read SEC document |
| February 05, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 2,000 | $0.55 | $1,100.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 8 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Read SEC document |
| February 01, 2019 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 7 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781 Read SEC document |
| December 20, 2018 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 3 | $0.26 | $0.78 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 6 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,481 Read SEC document |
| April 26, 2018 Filed Apr 30, 2018 21:59 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001078782-18-000491 · primary_doc.xml · derivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,423 Underlying: Common Stock · 50,000 shares Expires 2018-04-01 F1 · derivative.exercise_date: Option vests and becomes exercisable quarterly over four years. Read SEC document |
| January 24, 2018 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 400 | $0.37 | $148.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 5 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,478 Read SEC document |
| December 20, 2017 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 800 | $0.44 | $352.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 4 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,078 Read SEC document |
| April 07, 2017 Filed Feb 14, 2018 23:18 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 76,923 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001078782-18-000170 · primary_doc.xml · derivative · entry 2 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,923 shares Expires 2027-04-01 F2 · derivative.exercise_date: Options vest over one year. Read SEC document |
| March 30, 2017 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 4 | $0.25 | $1.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 3 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278 Read SEC document |
| March 15, 2017 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 500 | $0.30 | $150.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 2 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274 Read SEC document |
| March 07, 2017 Filed Apr 15, 2021 20:30 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon Stock | 500 | $0.42 | $210.00 |
DisclosureSEC source: 0001493152-21-008889 · ownership.xml · nonDerivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774 Read SEC document |
| April 01, 2016 Filed Feb 14, 2018 23:18 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001078782-18-000170 · primary_doc.xml · derivative · entry 1 Fell Donald G. · CIK 0001616905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-04-01 F1 · derivative.exercise_date: Options vest quarterly over four years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.